NCT05668780View on ClinicalTrials.gov

Buprenorphine Integration Research and Community Health

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 24, 2023

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Opioid Use DisorderHIV InfectionsHepatitis C
Interventions
BEHAVIORAL

NIATx Coaching

"The intervention will consist of:~1. a Nominal Group Technique session to identify priorities in integrating HIV/HCV/MOUD~2. rapid cycle improvement coaching sessions from a NIATx coach, using data dashboards and screening alerts to improve identification and treatment for HIV/HCV/OUD~3. training for primary care providers"

Trial Locations (1)

26506

West Virginia University, Morgantown

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

West Virginia University

OTHER

lead

Yale University

OTHER